iNtRON Biotechnology Inc
048530
Company Profile
Business description
iNtRON Biotechnology Inc is a Korea-based company principally engaged in the biotechnology industry. It develops, manufactures, and commercializes drugs for the treatment of infectious diseases. It is contributing to national health and national prevention through several (molecular) diagnostic products such as swine flu, VRE super bacteria, food poisoning, avian influenza and foot, and mouth disease. In addition, it is also engaged in the operation of a veterinary antibiotic alternative business and new biopharmaceuticals development business.
Contact
137, Sagimakgol-ro, Jungwon-gu
Gyeonggi-do
Seongnam-si
KORT: +82 317395678
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
78
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,793.10 | 120.80 | -1.53% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,913.25 | 233.77 | 3.04% |
| HKSE | 20,552.36 | 129.42 | -0.63% |
| NASDAQ | 16,421.05 | 703.92 | -4.11% |
| Nikkei 225 | 33,066.95 | 1,542.05 | -4.46% |
| NZX 50 Index | 12,020.25 | 181.18 | -1.48% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,586.50 | 123.10 | -1.60% |
| SSE Composite Index | 3,229.17 | 5.54 | 0.17% |